These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 14504183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
    Rajagopalan S, Mohler E, Lederman RJ, Saucedo J, Mendelsohn FO, Olin J, Blebea J, Goldman C, Trachtenberg JD, Pressler M, Rasmussen H, Annex BH, Hirsch AT, Regional Angiogenesis With Vascular Endothelial Growth Factor trial.
    Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S, Närvänen O, Rantala A, Peuhkurinen K, Nieminen MS, Laakso M, Ylä-Herttuala S.
    Circulation; 2003 Jun 03; 107(21):2677-83. PubMed ID: 12742981
    [Abstract] [Full Text] [Related]

  • 5. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication.
    Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR.
    Circulation; 2011 Oct 18; 124(16):1765-73. PubMed ID: 21947297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. VEGF gene transfer for diabetic neuropathy.
    Isner JM, Ropper A, Hirst K.
    Hum Gene Ther; 2001 Aug 10; 12(12):1593-4. PubMed ID: 11529248
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication.
    Rajagopalan S, Trachtenberg J, Mohler E, Olin J, McBride S, Pak R, Rasmussen H, Crystal R.
    Am J Cardiol; 2002 Sep 01; 90(5):512-6. PubMed ID: 12208412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K, Närvänen O, Manninen H, Räsänen H, Hippeläinen M, Alhava E, Ylä-Herttuala S.
    J Gene Med; 2002 Sep 01; 4(4):371-80. PubMed ID: 12124979
    [Abstract] [Full Text] [Related]

  • 11. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA, Sellke FW, Laham RJ.
    Gene Ther; 2003 Feb 27; 10(4):285-91. PubMed ID: 12595887
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)].
    Banga JD.
    Ned Tijdschr Geneeskd; 2000 Jan 15; 144(3):113-6. PubMed ID: 10674116
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
    Schalch P, Rahman GF, Patejunas G, Goldschmidt RA, Carbray J, Retuerto MA, Kim D, Esser K, Crystal RG, Rosengart TK.
    J Thorac Cardiovasc Surg; 2004 Feb 15; 127(2):535-40. PubMed ID: 14762365
    [Abstract] [Full Text] [Related]

  • 16. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.
    Mohler ER, Rajagopalan S, Olin JW, Trachtenberg JD, Rasmussen H, Pak R, Crystal RG.
    Vasc Med; 2003 Feb 15; 8(1):9-13. PubMed ID: 12866606
    [Abstract] [Full Text] [Related]

  • 17. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V, Charlton P, Boyd A.
    Hum Gene Ther; 2001 Nov 01; 12(16):2025-7. PubMed ID: 11727735
    [Abstract] [Full Text] [Related]

  • 18. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2539-45. PubMed ID: 17174195
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic angiogenesis for ischemic syndromes.
    Weisz A, Koren B, Fischer L, Lewis BS, Flugelman MY.
    Isr Med Assoc J; 2000 Jul 19; 2 Suppl():52-7. PubMed ID: 10909418
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve.
    Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG.
    Circulation; 2001 Aug 14; 104(7):753-5. PubMed ID: 11502697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.